Copyright Reports & Markets. All rights reserved.

Global Pneumococcal Vaccines Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Pneumococcal Vaccines Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Product
      • 1.4.2 PPSV 23
      • 1.4.3 PCV 7/13
      • 1.4.4 PCV 10
    • 1.5 Market by End User
      • 1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by End User
      • 1.5.2 For Infants
      • 1.5.3 For Children (2-10)
      • 1.5.4 For Person (10-64)
      • 1.5.5 For The Old (≥65)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Pneumococcal Vaccines Market Size
      • 2.1.1 Global Pneumococcal Vaccines Revenue 2014-2025
      • 2.1.2 Global Pneumococcal Vaccines Sales 2014-2025
    • 2.2 Pneumococcal Vaccines Growth Rate by Regions
      • 2.2.1 Global Pneumococcal Vaccines Sales by Regions
      • 2.2.2 Global Pneumococcal Vaccines Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Pneumococcal Vaccines Sales by Manufacturers
      • 3.1.1 Pneumococcal Vaccines Sales by Manufacturers
      • 3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers
      • 3.1.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pneumococcal Vaccines Revenue by Manufacturers
      • 3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2014-2019)
    • 3.3 Pneumococcal Vaccines Price by Manufacturers
    • 3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
      • 3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Pneumococcal Vaccines Product Type
      • 3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Pneumococcal Vaccines Sales by Product
    • 4.2 Global Pneumococcal Vaccines Revenue by Product
    • 4.3 Pneumococcal Vaccines Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Pneumococcal Vaccines Breakdown Data by End User

    6 North America

    • 6.1 North America Pneumococcal Vaccines by Countries
      • 6.1.1 North America Pneumococcal Vaccines Sales by Countries
      • 6.1.2 North America Pneumococcal Vaccines Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Pneumococcal Vaccines by Product
    • 6.3 North America Pneumococcal Vaccines by End User

    7 Europe

    • 7.1 Europe Pneumococcal Vaccines by Countries
      • 7.1.1 Europe Pneumococcal Vaccines Sales by Countries
      • 7.1.2 Europe Pneumococcal Vaccines Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Pneumococcal Vaccines by Product
    • 7.3 Europe Pneumococcal Vaccines by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Pneumococcal Vaccines by Countries
      • 8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries
      • 8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Pneumococcal Vaccines by Product
    • 8.3 Asia Pacific Pneumococcal Vaccines by End User

    9 Central & South America

    • 9.1 Central & South America Pneumococcal Vaccines by Countries
      • 9.1.1 Central & South America Pneumococcal Vaccines Sales by Countries
      • 9.1.2 Central & South America Pneumococcal Vaccines Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Pneumococcal Vaccines by Product
    • 9.3 Central & South America Pneumococcal Vaccines by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Pneumococcal Vaccines by Countries
      • 10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries
      • 10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Pneumococcal Vaccines by Product
    • 10.3 Middle East and Africa Pneumococcal Vaccines by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Pneumococcal Vaccines Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Pneumococcal Vaccines Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 GSK
      • 11.3.1 GSK Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 GSK Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 GSK Pneumococcal Vaccines Products Offered
      • 11.3.5 GSK Recent Development
    • 11.4 Merck
      • 11.4.1 Merck Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck Pneumococcal Vaccines Products Offered
      • 11.4.5 Merck Recent Development
    • 11.5 Eli Lilly
      • 11.5.1 Eli Lilly Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
      • 11.5.5 Eli Lilly Recent Development
    • 11.6 AstraZeneca
      • 11.6.1 AstraZeneca Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
      • 11.6.5 AstraZeneca Recent Development
    • 11.7 Abera
      • 11.7.1 Abera Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Abera Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Abera Pneumococcal Vaccines Products Offered
      • 11.7.5 Abera Recent Development
    • 11.8 S K Chemicals
      • 11.8.1 S K Chemicals Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
      • 11.8.5 S K Chemicals Recent Development
    • 11.9 Beijing Minhai Biotechnology
      • 11.9.1 Beijing Minhai Biotechnology Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
      • 11.9.5 Beijing Minhai Biotechnology Recent Development
    • 11.10 Baxter
      • 11.10.1 Baxter Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Baxter Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Baxter Pneumococcal Vaccines Products Offered
      • 11.10.5 Baxter Recent Development
    • 11.11 Biken
    • 11.12 Celgene Corporation
    • 11.13 Panacea Biotec
    • 11.14 Serum Institute of India
    • 11.15 Genentech
    • 11.16 Genocea Biosciences
    • 11.17 ImmunoBiology
    • 11.18 Lupin
    • 11.19 Nuron Biotech
    • 11.20 Biogen
    • 11.21 Valneva Austria
    • 11.22 Sinovac

    12 Future Forecast

    • 12.1 Pneumococcal Vaccines Market Forecast by Regions
      • 12.1.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2019-2025
    • 12.2 Pneumococcal Vaccines Market Forecast by Product
      • 12.2.1 Global Pneumococcal Vaccines Sales Forecast by Product 2019-2025
      • 12.2.2 Global Pneumococcal Vaccines Revenue Forecast by Product 2019-2025
    • 12.3 Pneumococcal Vaccines Market Forecast by End User
    • 12.4 North America Pneumococcal Vaccines Forecast
    • 12.5 Europe Pneumococcal Vaccines Forecast
    • 12.6 Asia Pacific Pneumococcal Vaccines Forecast
    • 12.7 Central & South America Pneumococcal Vaccines Forecast
    • 12.8 Middle East and Africa Pneumococcal Vaccines Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Pneumococcal Vaccines Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Pneumococcal Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccines market based on company, product type, end user and key regions.

      This report studies the global market size of Pneumococcal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccines in these regions.
      This research report categorizes the global Pneumococcal Vaccines market by top players/brands, region, type and end user. This report also studies the global Pneumococcal Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Sanofi
      GSK
      Merck
      Eli Lilly
      AstraZeneca
      Abera
      S K Chemicals
      Beijing Minhai Biotechnology
      Baxter
      Biken
      Celgene Corporation
      Panacea Biotec
      Serum Institute of India
      Genentech
      Genocea Biosciences
      ImmunoBiology
      Lupin
      Nuron Biotech
      Biogen
      Valneva Austria
      Sinovac

      Market size by Product
      PPSV 23
      PCV 7/13
      PCV 10
      Market size by End User
      For Infants
      For Children (2-10)
      For Person (10-64)
      For The Old (≥65)

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Pneumococcal Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Pneumococcal Vaccines market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Pneumococcal Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Pneumococcal Vaccines submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Pneumococcal Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now